| Literature DB >> 23706119 |
Enrique Serrano Ostariz, Marta López Ramón, Daniel Cremades Arroyos, Silvia Izquierdo Álvarez, Pilar Catalán Edo, Cristina Baquer Sahún, Alejandro Legaz Arrese.
Abstract
BACKGROUND: In this research, an extension to our previous work published in the Clinical Journal of Sports Medicine in 2009, we studied subjects that differed in terms of age and training status and assessed the impact of prolonged exercise on systolic and left ventricular diastolic function and cardiac biomarkers levels, recognized as identifiers of cardiac damage and dysfunction. We also assessed the possible influence of event duration, exercise intensity and weight loss (dehydration) on left ventricular diastolic function.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23706119 PMCID: PMC3671965 DOI: 10.1186/1756-0500-6-211
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Pre and post-race data (mean ± standard deviation)
| LVIDd (mm) | 51.2 ± 4.0 | 47.7 ± 4.6 | 0.000 |
| LVIDs (mm) | 29.3 ± 4.1 | 30.4 ± 4.3 | 0.018 |
| LVPWd (mm) | 9.6 ± 1.1 | 9.6 ± 0.9 | 0.80 |
| IVSDd (mm) | 9.6 ± 1.1 | 9.5 ± 1.0 | 0.58 |
| LVEF (%) | 67.7 ± 8.2 | 59.7 ± 9.4 | 0.000 |
| E/A | 1.6 ± 0.4 | 1.1 ± 0.3 | 0.000 |
| cTnI (μg L-1) | 0.006 ± 0.015 | 0.056 ± 0.059 | 0.000 |
| NT-proBNP (ng L-1) | 27 ± 16 | 189 ± 111 | 0.000 |
| HR (per min) | 58 ± 8 | 86 ± 11 | 0.000 |
| BPS (mmHg) | 125 ± 12 | 110 ± 12 | 0.000 |
| BPD (mmHg) | 65 ± 10 | 62 ± 111 | 0.049 |
| Ht (%) | 43.3 ± 2.1 | 44.6 ± 2.9 | 0.000 |
| Weight (kg) | 74.3 ± 8.4 | 72.0 ± 8.5 | 0.000 |
Abbreviations: BPD diastolic blood pressure, BPS systolic blood pressure, cTnI cardiac troponin I, E/A ratio of early to late peak diastolic transmitral flow velocities, H R heart rate, Ht haematocrit, IVSDd interventricular septum thickness during diastole, LVEF left ventricular ejection fraction, LVIDd left ventricular internal dimension during diastole, LVIDs left ventricular internal dimension during systole, LVPWd left ventricular posterior wall thickness during diastole, NT-proBNP N-terminal pro-brain natriuretic peptide.